Education and public awareness are crucial for patients navigating BCG-unresponsive non-muscle invasive bladder cancer treatment options.

Dr. Vinayak Venkataraman, medical oncologist and director of Sarcoma Pathways at Dana-Farber Cancer Institute in Boston, ...

Dr. Anjana Pillai explains, in an interview with CURE, that treatment for liver cancer depends heavily on stage, liver ...

Compartmentalizing the diagnosis allowed her to continue working, using her professional life as a refuge during treatment.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...

On Sept. 5, 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo (gemcitabine intravesical system) for adults ...

Exousia Pro, Inc., a clinical-stage biotech company that specializes in the use of exomes to treat cancer and other illnesses ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Scalp cooling helped Maureen Green feel more like herself during chemotherapy, giving her control over her appearance at a ...

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as ...

Introduction: October marks Breast Cancer Awareness Month, a chance to recognize survivors and support those currently in ...